Clinical trial
Bioavailability Study Comparing Two New Nilotinib Tablet Formulations to an…
NCT00418769 · Novartis Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00418769 |
|---|---|
| Title | Bioavailability Study Comparing Two New Nilotinib Tablet Formulations to an Established Nilotinib Capsule Formulation in Healthy Volunteers |
| Official title | A Randomized, Open Label, Two-arm, Three Period Crossover Bioavailability Study Comparing Two New Nilotinib Tablet Formulations to an Established Nilotinib Capsule Formulation in Healthy Volunteers |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | Nilotinib |
| Enrollment | 24 |
| Start date | Jun 1, 2006 |
| Primary completion | Aug 1, 2006 |
| First posted | Jan 5, 2007 |
| Last update posted | Dec 9, 2020 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: